TLR2 and B-cell chronic lymphocytic leukemia: Furthermore, the TLR2-rs4696480 variant has been shown to increase the risk of follicular lymphoma (FL), whereas it decreases the risk of chronic lymphocytic leukemia (CLL) (195).